Identification of native, immunogenic peptides from Cyclin D1

Leukemia

Volumn 24, Issue 1, 2010, Pages 209-211

  Von Bergwelt Baildon, M S ^a   Shimabukuro Vornhagen, A ^a   Wendtner, C M ^a   Kondo, E ^b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; EPITOPE; HLA ANTIGEN; PEPTIDE DERIVATIVE;

AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CANCER CELL; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CELL EXPANSION; CYTOTOXIC T LYMPHOCYTE; HUMAN; LETTER; MANTLE CELL LYMPHOMA; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN TARGETING;

EID: 74249109339     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2009.184     Document Type: Letter

References (9)

1. Wang M, Sun L, Qian J, Han X, Zhang L, Lin P et al. Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy. Leukemia 2009; 23: 1320-1328.
2. Kondo E, Maecker B, Weihrauch MR, Wickenhauser C, Zeng W, Nadler LM et al. Cyclin D1-specific cytotoxic T lymphocytes are present in the repertoire of cancer patients: implications for cancer immunotherapy. Clin Cancer Res 2008; 14: 6574-6579.
3. Kondo E, Gryschok L, Schultze JL, von Bergwelt-Baildon MS. Using CD40-activated B cells to efficiently identify epitopes of tumor antigens. J Immunother 2009; 32: 157-160.
4. Sadovnikova E, Jopling LA, Soo KS, Stauss HJ. Generation of human tumor-reactive cytotoxic T cells against peptides presented by non-self HLA class I molecules. Eur J Immunol 1998; 28: 193-200.
5. Kessler JH, Melief CJ. Identification of T-cell epitopes for cancer immunotherapy. Leukemia 2007; 21: 1859-1874.
6. Alexander-Miller MA, Leggatt GR, Berzofsky JA. Selective expansion of high-or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc Natl Acad Sci USA 1996; 93: 4102-4107.
7. Kondo E, Maecker B, Draube A, Klein-Gonzalez N, Shimabukuro-Vornhagen A, Schultze JL et al. The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells. Int J Cancer 2009, E-pub ahead of print 8 June 2009, DOI: 10.1002/ijc.24629.
8. Speiser DE, Baumgaertner P, Voelter V, Devevre E, Barbey C, Rufer N et al. Unmodified self antigen triggers human CD8T cells with stronger tumor reactivity than altered antigen. Proc Natl Acad Sci USA 2008; 105: 3849-3854.
9. Rubio V, Stuge TB, Singh N, Betts MR, Weber JS, Roederer M et al. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat Med 2003; 9: 1377-1382.